These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25104582)

  • 21. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
    Pickar JH; Amadio JM; Hill JM; Bernick BA; Mirkin S
    Menopause; 2016 May; 23(5):506-10. PubMed ID: 26836245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of high molecular weight hyaluronic acid in postmenopausal vaginal discomfort.
    Grimaldi EF; Restaino S; Inglese S; Foltran L; Sorz A; Di Lorenzo G; Guaschino S
    Minerva Ginecol; 2012 Aug; 64(4):321-9. PubMed ID: 22728576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.
    Archer DF
    J Steroid Biochem Mol Biol; 2015 Jan; 145():139-43. PubMed ID: 25201455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial.
    Kingsberg SA; Derogatis L; Simon JA; Constantine GD; Graham S; Bernick B; Gasper G; Mirkin S
    J Sex Med; 2016 Dec; 13(12):1930-1937. PubMed ID: 27692842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a randomized, placebo-controlled study.
    Fernandes T; Pedro AO; Baccaro LF; Costa-Paiva LH
    Menopause; 2018 Jun; 25(6):641-647. PubMed ID: 29462095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study.
    Palma F; Volpe A; Villa P; Cagnacci A;
    Maturitas; 2016 Jan; 83():40-4. PubMed ID: 26421474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.
    Bachmann GA; Komi JO;
    Menopause; 2010; 17(3):480-6. PubMed ID: 20032798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life.
    Gaspard U; Taziaux M; Jost M; Coelingh Bennink HJT; Utian WH; Lobo RA; Foidart JM
    Menopause; 2023 May; 30(5):480-489. PubMed ID: 36809193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy.
    Bruyniks N; Nappi RE; Castelo-Branco C; de Villiers TJ; Simon J
    Climacteric; 2016; 19(1):60-5. PubMed ID: 26669628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
    Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
    Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of soy isoflavones for subjective symptoms and objective signs of vaginal atrophy in menopause: A systematic review of randomised controlled trials.
    Ghazanfarpour M; Sadeghi R; Roudsari RL
    J Obstet Gynaecol; 2016; 36(2):160-71. PubMed ID: 26440219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women.
    Tucker KM; Godha K; Mirkin S; Archer DF
    Menopause; 2018 Jul; 25(7):762-766. PubMed ID: 29509598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
    Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal epithelial histology before and after fractional CO
    Li FG; Fuchs T; Deans R; McCormack L; Nesbitt-Hawes E; Abbott J; Farnsworth A
    Am J Obstet Gynecol; 2023 Sep; 229(3):278.e1-278.e9. PubMed ID: 37192705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial.
    Torky HA; Taha A; Marie H; El-Desouky E; Raslan O; Moussa AA; Ahmad AM; Abo-Louz A; Zaki S; Fares T; Eesa A
    Climacteric; 2018 Apr; 21(2):174-178. PubMed ID: 29347848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data review.
    Simon JA; Archer DF; Constantine GD; Pickar JH; Amadio JM; Bernick B; Graham S; Mirkin S
    Maturitas; 2017 May; 99():51-58. PubMed ID: 28364869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.